For help on how to get the results you want, see our search tips.
41 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Veterinary medicine European public assessment report (EPAR): Bluevac BTV8
bluetongue virus vaccine, serotype 8 (inactivated), Sheep, Cattle
Date of authorisation: 14/04/2011,
, Revision: 6, Authorised, Last updated: 06/03/2018
-
List item
Human medicine European public assessment report (EPAR): Brineura
cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017,
, , 
, 
, Revision: 3, Authorised, Last updated: 19/02/2020
-
List item
Human medicine European public assessment report (EPAR): Cabometyx
cabozantinib s-malate, Carcinoma, Renal Cell
Date of authorisation: 09/09/2016,, , Revision: 7, Authorised, Last updated: 13/02/2020
-
List item
Human medicine European public assessment report (EPAR): Coagadex
Human coagulation factor X, Factor X Deficiency
Date of authorisation: 16/03/2016,, , , Revision: 5, Authorised, Last updated: 21/04/2020
-
List item
Human medicine European public assessment report (EPAR): Darzalex
Daratumumab, Multiple Myeloma
Date of authorisation: 20/05/2016,, , , Revision: 11, Authorised, Last updated: 23/01/2020
-
List item
Human medicine European public assessment report (EPAR): Empliciti
Elotuzumab, Multiple Myeloma
Date of authorisation: 11/05/2016,, , Revision: 6, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Epclusa
Sofosbuvir, velpatasvir, Hepatitis C, Chronic
Date of authorisation: 06/07/2016,, , Revision: 12, Authorised, Last updated: 31/03/2020
-
List item
Human medicine European public assessment report (EPAR): Exviera
dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, , Revision: 17, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Harvoni (updated)
ledipasvir, Sofosbuvir, Hepatitis C, Chronic
Date of authorisation: 17/11/2014,, , Revision: 20, Authorised, Last updated: 19/05/2020
-
List item
Human medicine European public assessment report (EPAR): Hemlibra
Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018,, , Revision: 5, Authorised, Last updated: 05/06/2019
-
List item
Human medicine European public assessment report (EPAR): Iclusig
ponatinib, Leukemia, Myeloid, Leukemia, Lymphoid
Date of authorisation: 01/07/2013,, , , Revision: 20, Authorised, Last updated: 29/10/2019
-
List item
Human medicine European public assessment report (EPAR): Isentress
Raltegravir, HIV Infections
Date of authorisation: 19/12/2007,, Revision: 36, Authorised, Last updated: 25/06/2019
-
List item
Human medicine European public assessment report (EPAR): Jorveza
budesonide, Esophageal Diseases
Date of authorisation: 08/01/2018,, , Revision: 1, Authorised, Last updated: 16/07/2019
-
List item
Human medicine European public assessment report (EPAR): Kalydeco
ivacaftor, Cystic Fibrosis
Date of authorisation: 22/07/2012,, , Revision: 21, Authorised, Last updated: 03/02/2020
-
List item
Human medicine European public assessment report (EPAR): Kanuma
sebelipase alfa, Lipid Metabolism, Inborn Errors
Date of authorisation: 28/08/2015,, , , Revision: 4, Authorised, Last updated: 04/05/2020
-
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA
Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014,, , , Revision: 10, Authorised, Last updated: 10/01/2020
-
List item
Human medicine European public assessment report (EPAR): Kisplyx
lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016,, , Revision: 10, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kyprolis
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015,, , , Revision: 15, Authorised, Last updated: 07/01/2020
-
List item
Human medicine European public assessment report (EPAR): Lenvima
lenvatinib mesylate, Thyroid Neoplasms
Date of authorisation: 28/05/2015,, , Revision: 10, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Maviret
glecaprevir / pibrentasvir, Hepatitis C, Chronic
Date of authorisation: 26/07/2017,, , Revision: 8, Authorised, Last updated: 16/10/2019
-
List item
Veterinary medicine European public assessment report (EPAR): Nobilis Influenza H5N2
inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86), Chicken
Date of authorisation: 01/09/2006,, Revision: 7, Authorised, Last updated: 20/07/2016
-
List item
Human medicine European public assessment report (EPAR): Ofev (updated)
nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015,, , Revision: 13, Authorised, Last updated: 08/05/2020
-
List item
Human medicine European public assessment report (EPAR): Onpattro
patisiran sodium, Amyloidosis, Familial
Date of authorisation: 27/08/2018,, , , Revision: 3, Authorised, Last updated: 22/08/2019
-
List item
Human medicine European public assessment report (EPAR): Oxervate
recombinant human Nerve Growth factor (rhNGF), Keratitis
Date of authorisation: 06/07/2017,, , , Authorised, Last updated: 25/07/2017
-
List item
Human medicine European public assessment report (EPAR): Praxbind
idarucizumab, Hemorrhage
Date of authorisation: 20/11/2015,, , Revision: 6, Authorised, Last updated: 05/03/2020